Medicines Sans Frontiers (Doctors Without Borders), the International Aid group has expressed some serious concerns about pharmaceutical companies holding the power to decide who gets access to a vaccine, when, and at what price.
We’ve compiled a list of COVID vaccine front runners and how much will the vaccine cost possibly.
Moderna is a US-based biotechnology company that has chosen to charge governments somewhere in the range of $25 and $37 per portion for its Coronavirus vaccine, upon the sum requested by the governments. According to Stephane Bancel, CEO of Moderna, their vaccine will cost around $10 to $50 same as the flu vaccine.
Pfizer and BioNTech:
Another US-based biotechnology company alongside German biotechnology company BioNTech just recently announced that their COVID vaccine provides 90% immunity to coronavirus. Both biotechnological companies have agreed upon charging $20 per dose of their vaccine.
Sinovac Biotech, a Chinese bio pharmaceutical company has stated they’ve started their third phase of coronavirus vaccine testing in Brazil. The main motive behind the company’s initiative was to administrate the vaccine for front-line workers and high-risk individuals in Jiaxing, a city of China’s Zhejiang province, under the national emergency program.The single dose of vaccine will cost$30, as revealed by Jiaxing’s Center for Disease Control and Prevention (CDC).
Johnson & Johnson:
Johnson & Johnson stopped their coronavirus vaccine trial last month due to the study that showed that the individual developed an unexplained illness. The company has resumed its trials and have announced that their single dose of vaccine will cost $10.
The Russian coronavirus vaccine has claimed to be 92% effective for the infection, these claims were made by the Russian Direct Investment Fund (RDIF). RDIF also published last stage clinical trials result. The prices of the vaccine haven’t been announced yet by RDIF, but it is anticipated that the prices will be lesser than the Moderna and Pfizer Biotech’s vaccine.
The British company AstraZeneca in collaboration with Oxford University has also developed a coronavirus vaccine and they have claimed that their vaccine offers significant immunity to high-risk age groups individuals. According to the British company, the vaccine will $4 per dose.
Earlier this year in May, Novavax had acquired Czech Republic-based Praha Vaccines for $167 million, aiming to roll out 1 billion doses of its COVID-19 vaccine in 2021. The US-based vaccine development company has set the price of each dose of its Coronavirus vaccine at $16.